Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.682

  3034

  PDF: 1469
• 

  Are biological drugs safe in pregnancy?

  A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

  304-317

  31-03-2015

  https://doi.org/10.4081/reumatismo.2014.798

  4213

  PDF: 2648
• 

  On the history of biological drugs: the true discovery of the IL-1 receptor antagonist

  L. Punzi, P. Marson

  180

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.180

  956

  PDF (Italian): 455
• 

  Possible relationship between certolizumab pegol and arrhythmias: report of two cases

  R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

  104-108

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.869

  1982

  PDF: 1125
• 

  The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

  M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

  188-194

  31-12-2016

  https://doi.org/10.4081/reumatismo.2016.903

  2286

  PDF: 1072
• 

  IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

  S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

  40-43

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.40

  1160

  PDF: 1744
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.185

  1810

  PDF: 1342

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1306

  PDF: 878

• PO:01:015 | Assessment of the impact of the co-occurrence of psoriasis on the clinical and therapeutic pattern of a single-centre cohort of patients with spondyloarthritis associated with chronic inflammatory bowel disease Andrea Pace¹, Marcella Falconi¹, Alberto Floris^1|2, Leonardo Sichi¹, Francesca Onnis³, Lorenzo Meli³, Raffaela Piras³, Nicola Lutzu³, Federica Olla³, Agnese Favale³, Sara Onali³, Massimo Claudio Fantini³, Matteo Piga^1|2, Alberto Cauli^1|2. | ¹SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari, Cagliari, Italy; ²SC Reumatologia, AOU Cagliari, Cagliari, Italy; ³SC Gastroenterologia, AOU Cagliari, Cagliari, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2006

  201
• 

  Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

  M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1544

  1536

  PDF: 798

• PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2043

  166

• The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects

  A. Corrado, F.P. Cantatore

  142-153

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.142

  1069

  PDF: 2007

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  https://doi.org/10.4081/reumatismo.2009.197

  1326

  PDF: 1004
• 

  Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

  Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

  27-01-2025

  https://doi.org/10.4081/reumatismo.2025.1694

  2717

  PDF: 442

• Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes

  M. Filippini, G. Fontana, P. Bizioli, F. Crisafulli, R. Orabona, S. Zatti, F. Franceschini, A. Tincani

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1697

  1920

  PDF: 912

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  https://doi.org/10.4081/reumatismo.2008.290

  2327

  PDF: 1180

• PO:17:248 | Prevention of human papillomavirus infection in women with systemic lupus erythematosus: a single-center cross-sectional study Clizia Gagliardi¹, Maria Chiara Gerardi¹, Bianca Lucia Palermo¹, Giulia Carrea¹, Maria Di Cicco¹, Elena Manna¹, Giulia Segatto¹, Antonella Adinolfi¹, Laura Belloli¹, Cinzia Casu¹, Silvia Cavalli¹, Davide Antonio Filippini¹, Matteo Longhi¹, Gabriella Maioli¹, Martina Schettino¹, Nicola Ughi¹, Elisa Verduci¹, Arianna Bertolucci¹, Lara Buffa¹, Giulia Buonsante¹, Claudia Cordini¹, Eleonora Giacobbe¹, Francesco Molica Colella¹, Oscar Epis¹ | ¹ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2165

  201

• On the main stages of the history of intra-articular therapy

  P. Marson, G. Pasero, L. Punzi, G. Zanchin

  262-268

  https://doi.org/10.4081/reumatismo.2007.262

  1614

  PDF: 1246

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  https://doi.org/10.4081/reumatismo.2009.132

  2188

  PDF: 1226
• 

  The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

  N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1470

  10253

  PDF: 2334

• CO:10:3 | Clinical response to JAK inhibitors or non-TNFi-targeted biologicals according to synovial tissue characteristics in patients with difficult-to-treat rheumatoid arthritis Mariangela Salvato¹, Alessandro Giollo¹, Francesca Frizzera¹, Kiren Khalid¹, Lorenzo Di Luozzo¹, Maria Capita¹, Marianna Tamussin¹, Carlo Garaffoni², Marny Fedrigo³, Annalisa Angelini³, Ettore Silvagni², Andrea Doria¹. | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova; ²Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna; ³Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1992

  209
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  2027

  PDF: 1161

• PO:07:098 | Reasons for treatment failure and their synovial correlate among patients with difficult-to-treat rheumatoid arthritis Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Kiren Khalid¹, Lorenzo Di Luozzo¹, Carlo Garaffoni², Maria Capita², Marianna Tamussin², Giovanni Lanza², Marny Fedrigo³, Annalisa Angelini³, Roberta Ramonda¹, Ettore Silvagni², Andrea Doria¹ | ¹UOC Reumatologia Padova, Italy; ²UOC Reumatologia Ferrara, Italy; ³UOC Patologia cardiovascolare Padova, Italy; ⁴UOC Anatomia Patologica Ferrara, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2304

  41
• 

  Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

  G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1559

  2189

  PDF: 1162

• PO:04:051 | Application of REMS in the assessment of fragility score and bone mineral density in axial spondyloarthritis and psoriatic arthritis with axial involvement Silvia Valentini¹, Stefano Gentileschi¹, Pamela Bernardini², Jurgen Sota¹, Caterina Baldi¹, Sara Torracchi², Daniela Melchiorre², Sabrina Aliberti², Emilio D'Ignazio¹, Carla Caffarelli³, Luca Cantarini¹, Serena Guiducci², Bruno Frediani¹ | ¹UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena; ²SOD Reumatologia, Dipartimento di Medicina Sperimentale e clinica, Università degli studi di Firenze, AOU Careggi; ³UOC Medicina Interna e della Complessità, Dipartimento di Scienze Mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2129

  180

• Safety of anti-TNFa biological drugs

  F. Trotta, G. Valentini

  34-39

  https://doi.org/10.4081/reumatismo.2005.4s.34

  1378

  PDF: 1488
• 

  Severe Behçet’s disease equally affects both genders in Egyptian patients: A multicentre retrospective follow-up study

  D.H.S. Attia, R.A. Abdel Noor

  218-225

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1223

  1665

  PDF: 917

• Are there differences among anti-TNFa biological drugs?

  G. Valesini

  1-2

  https://doi.org/10.4081/reumatismo.2005.4s.1

  914

  PDF: 672

• PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology Davide Rozza¹, Carlo Alberto Scirè^1|2, Paola Conigliaro³, Giacomo Emmi⁴, Laura Coladonato⁶, Salvatore Scarpato⁷, Luca Iaccarino⁸, Serena Guiducci⁹, Giulia Pazzola¹⁰, Francesca Romana Spinelli¹¹, Micol Frassi¹², Ilaria Cavazzana¹², Chiara Scirocco¹³, Valeria Orefice¹³, Immacolata Prevete¹³, Alessandra Bortoluzzi¹⁴, Marcello Govoni¹⁴, Elena Bartoloni¹⁵, Luca Moroni¹⁶, Giuseppe Alvise Ramirez¹⁶, Valentina Canti¹⁶, Giorgio Pettiti¹⁷, Maria Chiara Ditto¹⁸, Enrico Fusaro¹⁸, Marta Mosca¹⁹, Lorenzo Cavagna²⁰, Fabrizio Conti¹¹, Andrea Doria⁸, Gian Domenico Sebastiani¹³, Sperimentatori Gruppo Lire⁵ | ¹Centro Studi della Società Italiana di Reumatologia, Milano; ²Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; ³Università di Roma Tor Vergata; ⁴Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; ⁵https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; ⁶Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; ⁷Azienda Sanitaria Locale ^ASL Salerno; ⁸Università degli Studi di Padova; ⁹SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; ¹⁰Arcispedale Santa Maria Nuova Reggio Emilia; ¹¹Università degli Studi di Roma La Sapienza; ¹²Spedali Civili di Brescia; ¹³Azienda Ospedaliera San Camillo Forlanini, Roma; ¹⁴Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; ¹⁵SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; ¹⁶IRCCS Ospedale San Raffaele, Milano; ¹⁷Azienda Ospedaliera S. Croce e Carle, Cuneo; ¹⁸AOU Citta' della Salute e della Scienza di Torino; ¹⁹AOU Santa Chiara, Pisa; ²⁰Università di Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2158

  180

• Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

  S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti

  22-27

  https://doi.org/10.4081/reumatismo.2008.22

  1313

  PDF: 1116

• CO:02:4 | Whole blood hypercoagulable profiles in patients with rheumatoid arthritis Lorenzo Di Luozzo¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Kiren Khalid¹, Luca Spiezia², Andrea Benetti², Chiara Samà², Paolo Simioni², Andrea Doria¹. | ^1Unità di Reumatologia, Azienda Ospedaliera di Padova; ²Dipartimento di Medicina, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1967

  256
• 

  The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases

  Chiara Crotti, Nicola Ughi, Emanuela Beretta, Antonio Luca Brucato, Greta Carrara, Maria Sole Chimenti, Paola Conigliaro, Francesca Crisafulli, Giovanna Cuomo, Emma Di Poi, Khadija El Auofy, Micaela Fredi, Maria Chiara Gerardi, Maria Gerosa, Ariela Hoxa, Aurora Ianniello, Maddalena Larosa, Danila Morano, Marta Mosca, Mario Motta, Martina Orlandi, Melissa Padovan, Davide Rozza, Savino Sciascia, Silvia Tonolo, Simona Truglia, Maria Letizia Urban, Anna Zanetti, Sonia Zatti, Angela Tincani

  12-02-2025

  https://doi.org/10.4081/reumatismo.2025.1752

  3162

  PDF: 901

  SUPPLEMENTARY MATERIAL: 287

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  https://doi.org/10.4081/reumatismo.2008.61

  1337

  PDF: 967